New concepts in pharmacological efficacy at 7TM receptors: IUPHAR Review 2

被引:108
作者
Kenakin, Terry [1 ]
机构
[1] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA
关键词
receptor theory; agonism; efficacy; drug discovery; BETA(2) ADRENERGIC-RECEPTOR; MULTIPLE G-PROTEINS; INHIBIT ADENYLYL-CYCLASE; ARRESTIN-BIASED LIGAND; DELTA-OPIOID RECEPTORS; TERNARY COMPLEX MODEL; FUNCTIONAL SELECTIVITY; CONFORMATIONAL-CHANGES; ALLOSTERIC MODULATION; PARATHYROID-HORMONE;
D O I
10.1111/j.1476-5381.2012.02223.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The present-day concept of drug efficacy has changed completely from its original description as the property of agonists that causes tissue activation. The ability to visualize the multiple behaviours of seven transmembrane receptors has shown that drugs can have many efficacies and also that the transduction of drug stimulus to various cellular stimulusresponse cascades can be biased towards some but not all pathways. This latter effect leads to agonist functional selectivity, which can be favourable for the improvement of agonist therapeutics. However, in addition, biased agonist potency becomes cell type dependent with the loss of the monotonic behaviour of stimulusresponse mechanisms, leading to potential problems in agonist quantification. This has an extremely important effect on the discovery process for new agonists since it now cannot be assumed that a given screening or lead optimization assay will correctly predict therapeutic behaviour. This review discusses these ideas and how new approaches to quantifying agonist effect may be used to circumvent the cell type dependence of agonism. This article, written by a corresponding member of the International Union of Basic and Clinical Pharmacology Committee on Receptor Nomenclature and Drug Classification (NC-IUPHAR), reviews our current understanding of the interaction of ligands with seven transmembrane receptors. Further information on these pharmacological concepts is being incorporated into the IUPHAR/BPS database GuideToPharmacology.org. Linked Articles This article is the second in a series of reviews on pharmacological themes commissioned by NC-IUPHAR and accompanies the long-standing series of articles on pharmacological nomenclature published in Pharmacological Reviews. For a listing of all publications of NC-IUPHAR see http://www.iuphar-db.org/nciupharPublications.jsp. Pharmacological Reviews articles on the principles and terminology of functional selectivity for GPCRs and on the principles of allosterism are being prepared for publication in early 2013.
引用
收藏
页码:554 / 575
页数:22
相关论文
共 170 条
[1]   Special Issue: Guide to Receptors and Channels, 5th Edition Abstracts [J].
Alexander, Stephen P. H. ;
Mathie, Alistair ;
Peters, John A. .
BRITISH JOURNAL OF PHARMACOLOGY, 2011, 164 :S1-+
[2]   Discovery of β-Arrestin-Biased Dopamine D2 Ligands for Probing Signal Transduction Pathways Essential for Antipsychotic Efficacy [J].
Allen, John A. ;
Yost, Julianne M. ;
Setola, Vincent ;
Chen, Xin ;
Sassano, Maria F. ;
Chen, Meng ;
Peterson, Sean ;
Yadav, Prem N. ;
Huang, Xi-ping ;
Feng, Bo ;
Jensen, Niels H. ;
Che, Xin ;
Bai, Xu ;
Frye, Stephen V. ;
Wetsel, William C. ;
Caron, Marc G. ;
Javitch, Jonathan A. ;
Roth, Bryan L. ;
Jin, Jian .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (45) :18488-18493
[3]   Developing Chemical Genetic Approaches to Explore G Protein-Coupled Receptor Function: Validation of the Use of a Receptor Activated Solely by Synthetic Ligand (RASSL) [J].
Alvarez-Curto, Elisa ;
Prihandoko, Rudi ;
Tautermann, Christofer S. ;
Zwier, Jurriaan M. ;
Pediani, John D. ;
Lohse, Martin J. ;
Hoffmann, Carsten ;
Tobin, Andrew B. ;
Milligan, Graeme .
MOLECULAR PHARMACOLOGY, 2011, 80 (06) :1033-1046
[4]  
Fang Ye, 2011, Drug Discov Today Technol, V7, pe5, DOI 10.1016/j.ddtec.2010.05.001
[5]  
[Anonymous], 2000, HANDB EXP PHARM
[6]  
ARIENS EJ, 1954, ARCH INT PHARMACOD T, V99, P32
[7]   Molecular characterization of a purified 5-HT4 receptor -: A structural basis for drug efficacy [J].
Banères, JL ;
Mesnier, D ;
Martin, A ;
Joubert, L ;
Dumuis, A ;
Bockaert, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (21) :20253-20260
[8]   Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: Evidence for agonist-directed trafficking of receptor stimulus [J].
Berg, KA ;
Maayani, S ;
Goldfarb, J ;
Scaramellini, C ;
Leff, P ;
Clarke, WP .
MOLECULAR PHARMACOLOGY, 1998, 54 (01) :94-104
[9]   A conservative, single-amino acid substitution in the second cytoplasmic domain of the human serotonin2C receptor alters both ligand-dependent and -independent receptor signaling [J].
Berg, Kelly A. ;
Dunlop, John ;
Sanchez, Teresa ;
Silva, Michelle ;
Clarke, William P. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 324 (03) :1084-1092
[10]   Ligand-stabilized conformational states of human β2 adrenergic receptor:: Insight into G-protein-coupled receptor activation [J].
Bhattacharya, Supriyo ;
Hall, Spencer E. ;
Li, Hubert ;
Vaidehi, Nagarajan .
BIOPHYSICAL JOURNAL, 2008, 94 (06) :2027-2042